AFT Pharmaceuticals Limited (AFP.AX)

2.8300 +0.1200 (+4.43%) At close: 10:11AM AEST

AFT Pharmaceuticals Limited

129 Hurstmere Road
Level 1 Takapuna
Auckland 0622
New Zealand
64 9 488 0232
https://www.aftpharm.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 100

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Hartley Atkinson Ph.D.	Co-Founder, CEO, MD & Executive Director	855.57k	N/A	N/A
Ms. Marree Atkinson	Co-Founder, Chief of Staff & Executive Director	147.85k	N/A	N/A
Mr. Malcolm Tubby B.A., BA(Hon's), ICAEW, ICANZ	CFO & Company Secretary	N/A	N/A	N/A
Mr. Murray Keith	Group Marketing Manager	N/A	N/A	N/A
Ms. Ioana Stanescu	Head of Drug Development	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.

Corporate governance

AFT Pharmaceuticals Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.